References
- Al-Azemi, M., Kyrou, D., Kolibianakis, E., Humaidan, P., Van Vaerenbergh, I., Devroey, P., & Fatemi, H.M. (2012). Elevated progesterone during ovarian stimulation for IVF. Reproductive Biomedicine Online, 24, 381–388.
- Blockeel, C., Baumgarten, M., De Vos, M., Verheyen, G., & Devroey, P. (2011). Administration of GnRH antagonists in case of elevated progesterone at initiation of the cycle: A prospective cohort study. Current Pharmaceutical Biotechnology, 12, 423–428.
- Bosch, E., Valencia, I., Escudero, E., Crespo, J., Simón, C., Remohí, J., & Pellicer, A. (2003). Premature luteinization during gonado- tropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertility & Sterility, 80, 1444–1449.
- Bosch, E., Labarta, E., Crespo, J., Simón, C., Remohí, J., Jenkins, J., & Pellicer, A. (2010). Circulating progesterone levels and ongoing pregnancy rates in controlled ovarian stimulation cycles for in vitro fertilization: Analysis of over 4000 cycles. Human Reproduction, 25, 2092–2100.
- Bourgain, C. & Devroey, P. (2007). Histologic and functional aspects of the endometrium in the implantatory phase. Gynecologic and Obstetric Investigation, 64, 131–133.
- Hamdine, O., Broekmans, F.J., Eijkemans, M.J., Lambalk, C.B., Fauser, B.C., Laven, J.S., & Macklon, N.S.; CETRO trial study group. (2013). Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: A randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6. Fertility and Sterility, 100, 867–874.
- Hayden, C. (2008). GnRH analogues: Applications in assisted reproductive techniques. European Journal of Endocrinology, 159, S17–25.
- Kolibianakis, E.M., Venetis, C.A., Bontis, J., & Tarlatzis, B.C. (2012). Significantly lower pregnancy rates in the presence of progesterone elevation in patients treated with GnRH antagonists and gonadotrophins: A systematic review and meta-analysis. Current Pharmaceutical Biotechnology, 13, 464–470.
- Kolibianakis, E.M., Zikopoulos, K., Smitz, J., Camus, M., Tournaye, H., Van Steirteghem, A.C., & Devroey, P. (2004). Elevated progesterone at initiation of stimulation is associated with a lower ongoing pregnancy rate after IVF using GnRH antagonists. Human Reproduction, 19, 1525–1529.
- Kyrou, D., Kolibianakis, E.M., Fatemi, H.M., Camus, M., Tournaye, H., Tarlatzis, B., & Devroey, P. (2011). High exposure to progesterone between the end of menstruation and the day of triggering final oocyte maturation is associated with a decreased probability of pregnancy in patients treated by in vitro fertilization and intracytoplasmic sperm injection. Fertility & Sterility, 96, 884–888.
- Papanikolaou, E.G., Kolibianakis, E., Pozzobon, C., Tank, P., Tournaye, H., Bourgain, C., et al. (2009). Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertility and Sterility, 91, 949–952.
- Papanikolaou, E., Pados, G., Grimbizis, G., Bili, E., Kyriazi, L., Polyzos, N.P., et al. (2012). GnRH-agonist versus GnRH-antagonist IVF cycles: Is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study. Human Reproduction, 27, 1822–1828.
- Shapiro, B.S., Daneshmand, S.T., Garner, F.C., Aguirre, M., Hudson, C., & Thomas, S. (2010). Embryo cryopreservation rescues cycles with premature luteinization. Fertility and Sterility, 93, 636–641.
- Ubaldi, F., Albano, C., Peukert, M., Riethmuller-Winzen, H., Camus, M., Smitz, J., et al. (1996). Subtle progesterone rise after the administration of the gonad- otrophin-releasing hormone antagonist cetrorelix in intracyto- plasmic sperm injection cycles. Human Reproduction, 11, 1405–1407.
- Venetis, C.A., Kolibianakis, E.M., Bosdou, J.K., & Tarlatzis, B.C. (2013). Progesterone elevation and probability of pregnancy after IVF: A systematic review and meta-analysis of over 60000 cycles. Human Reproduction Update, 19, 433–457.
- Verberg, M.F., Eijkemans, M.J., Heijnen, E.M., Broekmans, F.J., de Klerk, C., Fauser, B.C., & Macklon, N.S. (2008). Why do couples drop-out from IVF treatment? A prospective cohort study. Human Reproduction, 23, 2050–2055.
- Wu, K., Zhao, H., Liu, H., Li, M., Ma, S., Li, C., et al. (2014). Day 3 ET, single blastocyst transfer (SBT) or frozen-thawed embryo transfer (FET): Which is preferable for high responder patients in IVF/ICSI cycles? Journal of Assisted Reproduction and Genetics, 31, 275–278.